全文获取类型
收费全文 | 10937篇 |
免费 | 710篇 |
国内免费 | 65篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 977篇 |
妇产科学 | 504篇 |
基础医学 | 973篇 |
口腔科学 | 158篇 |
临床医学 | 1079篇 |
内科学 | 2867篇 |
皮肤病学 | 188篇 |
神经病学 | 823篇 |
特种医学 | 322篇 |
外国民族医学 | 5篇 |
外科学 | 1120篇 |
综合类 | 418篇 |
一般理论 | 4篇 |
预防医学 | 866篇 |
眼科学 | 180篇 |
药学 | 530篇 |
1篇 | |
中国医学 | 96篇 |
肿瘤学 | 565篇 |
出版年
2024年 | 13篇 |
2023年 | 111篇 |
2022年 | 184篇 |
2021年 | 212篇 |
2020年 | 181篇 |
2019年 | 116篇 |
2018年 | 231篇 |
2017年 | 185篇 |
2016年 | 219篇 |
2015年 | 208篇 |
2014年 | 185篇 |
2013年 | 411篇 |
2012年 | 850篇 |
2011年 | 870篇 |
2010年 | 318篇 |
2009年 | 276篇 |
2008年 | 694篇 |
2007年 | 812篇 |
2006年 | 732篇 |
2005年 | 753篇 |
2004年 | 831篇 |
2003年 | 773篇 |
2002年 | 644篇 |
2001年 | 487篇 |
2000年 | 194篇 |
1999年 | 141篇 |
1998年 | 147篇 |
1997年 | 75篇 |
1996年 | 66篇 |
1995年 | 50篇 |
1994年 | 49篇 |
1993年 | 38篇 |
1992年 | 57篇 |
1991年 | 60篇 |
1990年 | 52篇 |
1989年 | 35篇 |
1988年 | 35篇 |
1987年 | 45篇 |
1986年 | 35篇 |
1985年 | 36篇 |
1984年 | 25篇 |
1983年 | 21篇 |
1982年 | 16篇 |
1981年 | 15篇 |
1979年 | 17篇 |
1978年 | 16篇 |
1977年 | 14篇 |
1975年 | 16篇 |
1973年 | 14篇 |
1970年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Shane S. Bush NAN Policy Planning Committee 《Archives of clinical neuropsychology》2005,20(8):997-1007
Independent forensic neuropsychological examinations are performed by neuropsychologists who are hired as independent contractors by third parties to make determinations regarding neuropsychological functioning. The responsibilities of neuropsychologists when performing independent or court-ordered forensic examinations differ from those of clinical examinations. Because neuropsychological training typically occurs in clinical contexts, the transition to forensic contexts may result in uncertainty about how to negotiate the unique responsibilities of the forensic examiner role. Neuropsychologists are responsible for maintaining the highest standards of professional practice when performing independent and court-ordered forensic examinations. To reach and maintain the highest standards of practice, neuropsychologists must understand the unique relationships with retaining parties and examinees and strive to maintain true independence and objectivity. Although a true neuropsychologist-patient relationship is not considered to exist within the context of a forensic neuropsychological evaluation, neuropsychologists have ethical responsibilities to both the retaining party and the examinee. 相似文献
5.
Paul D. Mintz MD President AABB John D. Roback MD PhD Chairman NBF Grants Review Committee 《Transfusion》2005,45(S2):23S-23S
6.
7.
G. Lallement Didier Clarençon Catherine Masqueliez Dominique Baubichon Monique Galonnier Marie-France Burckhart Michel Peoc’h Jean Claude Mestries 《Archives of toxicology》1997,72(2):84-92
Organophosphorus nerve agents are still in use today in warfare and as terrorism compounds. Classical emergency treatment
of organophosphate poisoning includes the combined administration of a cholinesterase reactivator (an oxime), a muscarinic
cholinergic receptor antagonist (atropine) and a benzodiazepine anticonvulsant (diazepam). However, recent experiments with
primates have demonstrated that such treatment, even when administered immediately after organophosphate exposure, does not
rapidly restore normal electroencephalographic (EEG) activity and fails to totally prevent neuronal brain damage. The objective
of this study was to evaluate, in a realistic setting, the therapeutic benefit of administration of GK-11 (gacyclidine), an
antiglutamatergic compound, as a complement to the available emergency therapy against organophosphate poisoning. GK-11 was
injected at a dose of 0.1 mg/kg (i.v) after a 45-min latency period to heavily intoxicated (8 LD50) primates. Just after intoxication, man-equivalent doses of one autoinjector containing atropine/pralidoxime/diazepam were
administered. The effects of GK-11 were examined on survival, EEG activity, signs of toxicity, recovery after challenge and
central nervous system histology. The present data demonstrate that treatment with GK-11 prevents the mortality observed after
early administration of classical emergency medication alone. EEG recordings and clinical observations also revealed that
GK-11 prevented soman-induced seizures and motor convulsions. EEG analysis within the classical frequency bands (beta, theta,
alpha, delta) demonstrated that central activity was totally restored to normal after GK-11 treatment, but remained profoundly
altered in animals receiving atropine/pralidoxime/diazepam alone. GK-11 also markedly accelerated clinical recovery of soman-challenged
primates. Lastly, this drug totally prevented the neuropathology observed 3 weeks after soman exposure in animals treated
with classical emergency treatment alone. GK-11 represents a promising adjuvant therapy to the currently available emergency
polymedication to ensure optimal management of organophosphate poisoning in man. This drug is presently being evaluated in
a human clinical trial for a different neuroprotective indication.
Received: 16 June 1997 / Accepted: 23 September 1997 相似文献
8.
Anita MacDonald Dr Sandra Warrington Chairman Professional Development Committee 《Journal of human nutrition and dietetics》1990,3(2):71-77
At the present time, there are many fundamental issues coming from the Department of Health or from other national organizations, which will have an effect on the future development of the dietetic profession. The British Diatetic Association (BDA) Professional Development Committee will consider these issues, as and when appropriate, and will publish the information in the form of Briefing Papers.
The first Briefing Paper on 'Quality Assurance' was published by the BDA in November 1989. The second on 'Measuring clinical outcome' is published below. In each case the opinion of BDA members and specialist groups has been sought and the Professional Development Committee wishes to thank individuals and the specialist groups for their comments.
The Briefing Papers are intended to provide information and promote discussion among the membership. I would welcome further comments from readers, which may be directed to the British Dietetic Association Office. 相似文献
The first Briefing Paper on 'Quality Assurance' was published by the BDA in November 1989. The second on 'Measuring clinical outcome' is published below. In each case the opinion of BDA members and specialist groups has been sought and the Professional Development Committee wishes to thank individuals and the specialist groups for their comments.
The Briefing Papers are intended to provide information and promote discussion among the membership. I would welcome further comments from readers, which may be directed to the British Dietetic Association Office. 相似文献
9.
10.
F. Estelle R. Simons on Behalf of the Early Prevention of Asthma in Atopic Children Study Group 《Pediatric allergy and immunology》2007,18(6):535-542
There are more than 40 H(1)-antihistamines available worldwide. Most of these medications have never been optimally studied in prospective, randomized, double-masked, placebo-controlled trials in children. The aim was to perform a long-term study of levocetirizine safety in young atopic children. In the randomized, double-masked Early Prevention of Asthma in Atopic Children Study, 510 atopic children who were age 12-24 months at entry received either levocetirizine 0.125 mg/kg or placebo twice daily for 18 months. Safety was assessed by: reporting of adverse events, numbers of children discontinuing the study because of adverse events, height and body mass measurements, assessment of developmental milestones, and hematology and biochemistry tests. The population evaluated for safety consisted of 255 children given levocetirizine and 255 children given placebo. The treatment groups were similar demographically, and with regard to number of children with: one or more adverse events (levocetirizine, 96.9%; placebo, 95.7%); serious adverse events (levocetirizine, 12.2%; placebo, 14.5%); medication-attributed adverse events (levocetirizine, 5.1%; placebo, 6.3%); and adverse events that led to permanent discontinuation of study medication (levocetirizine, 2.0%; placebo, 1.2%). The most frequent adverse events related to: upper respiratory tract infections, transient gastroenteritis symptoms, or exacerbations of allergic diseases. There were no significant differences between the treatment groups in height, mass, attainment of developmental milestones, and hematology and biochemistry tests. The long-term safety of levocetirizine has been confirmed in young atopic children. 相似文献